JMIR Diabetes
Emerging technologies, medical devices, apps, sensors, and informatics to help people with diabetes
Editor-in-Chief:
Ricardo Correa, MD, EdD (Co-Editor-in-Chief), Cleveland Clinic, United States Sheyu Li, MD (Co-Editor-in-Chief), West China Hospital, Sichuan University, China
Impact Factor 2.6 CiteScore 4.7
Recent Articles

Digital health interventions, including artificial intelligence (AI)-driven solutions, offer promise for type 2 diabetes mellitus (T2DM) and prediabetes management through enhanced self-management, adherence, and personalization. However, engagement challenges and barriers, particularly among young adults and diverse populations, persist. Existing reviews emphasize clinical outcomes while neglecting engagement factors crucial to intervention success. This review highlights engagement barriers and facilitators, offering insights into improving digital health solutions for diabetes management.


The global prevalence of type 2 diabetes mellitus (T2DM) poses significant challenges due to its association with increased cardiovascular risk and complications like cardiovascular autonomic neuropathy. Measures derived from heart rate variability (HRV) and cardiorespiratory interactions quantified through frequency response function (FRF) and impulse response (IR) metrics reflect different aspects of autonomic regulation and may provide complementary physiological information relevant to diabetes-related autonomic alterations.


Older adults with diabetes frequently access their electronic health record (EHR) notes but often report difficulty understanding medical jargon and nonspecific self-care instructions. To address this communication gap, we developed SEE-Diabetes (Support-Engage-Empower-Diabetes), a patient-centered, EHR-integrated diabetes self-management support tool designed to embed tailored educational statements within the Assessment and Plan section of clinical notes.

Sulphonylureas are commonly prescribed for managing type 2 diabetes, yet treatment responses vary significantly among individuals. Although advances in machine learning (ML) may enhance predictive capabilities compared to traditional statistical methods, their practical utility in real-world clinical environments remains uncertain.

In the past decade, telehealth has transformed healthcare delivery by allowing patients more rapid and convenient access to necessary care without the cost and logistical challenges of traveling to a healthcare facility. Telehealth services can benefit patients with type 2 diabetes mellitus (T2DM) amidst a growing epidemic of T2DM in the United States that affects people of all ages and races. In 2020, 33 million people were diagnosed with this chronic disease, with the number expected to rise 50% by 2040. Telehealth facilitates regular contact between patients and their providers, especially when there are geographic barriers and time constraints prohibiting physical interaction, at little or no added cost to the patient and at their convenience.


Diabetes prediction requires accurate, privacy-preserving, and scalable solutions. Traditional machine learning (ML) models rely on centralized data, posing risks to data privacy and regulatory compliance. Moreover, healthcare settings are highly heterogeneous, with diverse participants, hospitals, clinics, and wearables, producing non-IID data and operating under varied computational constraints. Learning in isolation at individual institutions limits model generalizability and effectiveness. Collaborative federated learning (FL) enables institutions to jointly train models without sharing raw data, but current approaches often struggle with heterogeneity, security threats, and system coordination.

Preprints Open for Peer Review
Open Peer Review Period:
-
Open Peer Review Period:
-







